Our company participated in the seminar on "Improvement of quality standard of newborn bovine serum" in Chinese Pharmacopoeia
Release time:
2019-11-08
On November 5, 2019, the leaders and main technical staff of Wuhan Sanli Biotechnology Co., Ltd. were invited by China Association of Pharmaceutical Biotechnology to attend a seminar on the topic of Chinese Pharmacopoeia "Research on the improvement of quality standard of neonatal bovine serum" at China Academy of Food and Drug Inspection and Quarantine in Beijing.
Mr. Zhang Guorong, the leader of Wuhan Sanli Biotechnology Co., Ltd, exchanged views with the China Academy of Food and Drug Administration and experts on the improvement of quality standards of neonatal bovine serum and delivered an important speech. Ltd. made significant contributions to the revision of the 2010 and 2015 editions of the Pharmacopoeia of the People's Republic of China, and expressed that he would continue to actively participate in the research on the improvement of bovine serum quality standards and make contributions to the improvement of bovine serum quality and the revision of the Pharmacopoeia of the People's Republic of China. Dr. Zhao Lirong from Wuhan Sanli Biotechnology Co., Ltd. gave an excellent presentation on the detection of exogenous viruses in bovine serum.
Mr. Shen Qi, Director of China Academy of Food and Drug Administration (CAFA), summarized the meeting and fully affirmed the leading position of Wuhan Sanli Biotechnology Co.
previous page
previous page
Related news
2019-12-31
Contact information
Telephone
Address: Xingfu Fourth Road, Jiangxia Miaoshan Development Zone, Wuhan City
Follow us
